Life Sciences — In Focus: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences
What the research community has known for a long time recently became front-page news: Biomedical research has a diversity problem. Historically, clinical trials have enrolled primarily younger, white male participants. … Continue readingLife Sciences — In Focus: FDA Diversity Action Plans: Deciphering the Guidance and its Consequences